Keflor Oral Suspension Strawberry contains cefaclor, a second-generation cephalosporin antibiotic, at a concentration of 50 mg per 5 ml. It is indicated for the treatment of various bacterial infections caused by susceptible organisms, including respiratory tract infections such as bronchitis and pneumonia, otitis media, skin and soft tissue infections, and urinary tract infections. Cefaclor exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The oral suspension formulation with a strawberry flavor is designed to improve palatability and facilitate administration, particularly in pediatric patients. Dosage and duration of therapy should be determined based on the severity of infection, patient age, weight, and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and vomiting, as well as hypersensitivity reactions including rash and urticaria. Caution is advised in patients with a history of penicillin or cephalosporin allergy due to potential cross-reactivity. It is essential to complete the prescribed course to prevent the development of antibiotic resistance. Keflor Oral Suspension should be stored at controlled room temperature and shaken well before use to ensure uniform suspension. Consultation with a healthcare professional is recommended prior to initiation of therapy.